Eli Lilly & Co. (LLY)
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
Recs
worldwide distribution for diabetes and other diseases
Recs
big farma a bit undervalued, look for it to outpace the S&P this year
Recs
Recs
Recs
Mega Drugs
Recs
Medicine always in demand
Recs
Good product line with diabetes. Dibetes with obesity will be an epidemic
Recs
bullish rsi
Recs
Eli Lily is one of the best and most consistently well managed companies. It understand the ebb and tides.
Recs
potential buyout candidate
Recs
Aging/dividend
Recs
Under priced for it's value
Recs
Over 11% annualized revenue growth over the last 5 years and a solid pipeline position LLY to outperform the S&P.
Recs
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Good diovidend too.
Recs
Div & Yield: 1.70 (3.20%)
Recs
Huge cash position and CIALIS. Sex sells and when you make a drug that improves a persons sex life, the sky is the limit.
Recs
Dividend, dividend, dividend. And a Democratic congress and pres make this quite appealing.
Recs
expect to hit new lows
Recs
Pharaceuticals will suffer under this administration's plan for universal care
Recs
Drug in pipeline will drive earnings

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 145 1 2 3 4 5 6 7 8 Next »